ranolazine
Drug Details
- Generic Name
- ranolazine
- Brand Names
- Ranolazine
- Application Number
- ANDA213085
- Sponsor
- Jubilant Biosys limited
- NDC Codes
- 3
- Dosage Forms
- POWDER, TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- RANOLAZINE
Indications and Usage
1 INDICATIONS AND USAGE Ranolazine Extended-Release Tablets are indicated for the treatment of chronic angina. Ranolazine Extended-Release Tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti- platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine Extended-Release Tablets is an antianginal indicated for the treatment of chronic angina. ( 1 )